We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

EpiPen Maker Slams Sanofi's Bid To Exit Antitrust MDL

Law360 (December 3, 2018, 6:07 PM EST) -- Sanofi should not yet be allowed to leave multidistrict litigation to pursue claims elsewhere that EpiPen maker Mylan used anti-competitive practices to hurt sales of Sanofi’s competing emergency allergy treatment, Mylan...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.